SCHEMBL3924933

SCHEMBL3924933

Nc1ccc2c(c1)CCS2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
BLM P54132 1/20 0.38
MAPT P10636 5/20 0.35
KDM4E B2RXH2 3/20 0.35
LMNA P02545 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
VHL P40337 1/20 0.35
ELOC Q15369 1/20 0.35
ELOB Q15370 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
SLC6A4 P31645 2/20 0.34
GAA P10253 3/20 0.33
APAF1 O14727 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306285 0.83 MAPT (0.36) CASP1CASP7HSD17B10BLMMAPT
SCHEMBL17058062 0.77
SCHEMBL2062318 0.75 RYR2 (0.59) CASP1CASP7HSD17B10BLMMAPT
SCHEMBL30016658 0.74 CTSL (0.42) VHLELOCELOBSLC6A4TDP1
SCHEMBL468939 0.74 CTSL (0.42) MAPTKDM4EALDH1A1HPGDVHL
SCHEMBL18899426 0.74 ADRA2A (0.38) VHLELOCELOBSLC6A4RYR2
SCHEMBL11180283 0.74 VHL (0.56) MAPTKDM4ELMNAALDH1A1VHL
SCHEMBL3115309 0.74 CTSL (0.42) VHLELOCELOBSLC6A4TDP1
SCHEMBL5422777 0.74 DRD2 (0.39) HSD17B10LMNAALDH1A1VHLELOC
Hydrochloric Acid SCHEMBL20562683 0.74 KDM4E (0.42) HSD17B10BLMMAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023159307-A1 POLO-LIKE KINASE 4 (PLK4) INHIBITORS, PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF REPARE THERAPEUTICS INC. (CA) 2023-08-31 WO disclosed
EP-2852593-A1 SUBSTITUTED PYRROLOPYRIMIDINES Bayer Pharma Aktiengesellschaft (DE) 2015-04-01 EP disclosed
WO-2013174743-A1 SUBSTITUTED PYRROLOPYRIMIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-11-28 WO disclosed
EP-2035433-A1 CYANOQUINOLINE DERIVATIVES, THEIR PREPARATION, THEIR USE, AND MEDICAMENTS COMPRISING THEM Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-18 EP disclosed
WO-2007147576-A1 CYANOQUINOLINE DERIVATIVES, THEIR PREPARATION, THEIR USE, AND MEDICAMENTS COMPRISING THEM BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-12-27 WO disclosed